1 Clearance |
1 |
121 |
Risk Ratio (M‐H, Random, 95% CI) |
0.94 [0.62, 1.42] |
2 Adverse events: skin atrophy |
1 |
121 |
Risk Ratio (M‐H, Random, 95% CI) |
3.46 [1.36, 8.77] |
3 Adverse events: skin hypopigmentation |
1 |
121 |
Risk Ratio (M‐H, Random, 95% CI) |
3.05 [1.57, 5.93] |
4 Adverse events: minimal crusting |
1 |
22 |
Risk Ratio (M‐H, Random, 95% CI) |
5.0 [0.27, 93.55] |
5 Adverse events: pain |
1 |
22 |
Risk Ratio (M‐H, Random, 95% CI) |
5.0 [0.27, 93.55] |
6 Other measures of resolution: no redness |
1 |
121 |
Risk Ratio (M‐H, Random, 95% CI) |
4.83 [1.75, 13.36] |
7 Parents who consider that their child still has a problem |
1 |
121 |
Risk Ratio (M‐H, Random, 95% CI) |
1.24 [0.56, 2.78] |
8 Aesthetic appearance: better cosmetic outcome |
1 |
22 |
Risk Ratio (M‐H, Random, 95% CI) |
1.75 [0.71, 4.31] |
9 Requirement for surgical correction |
1 |
121 |
Risk Ratio (M‐H, Random, 95% CI) |
2.37 [0.64, 8.75] |